{"id":"https://openalex.org/W4241965367","doi":"https://doi.org/10.1016/j.bmcl.2004.11.072","title":"1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1","display_name":"1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1","alternate_titles":[],"publication_year":2004,"publication_date":"2004-12-29","ids":{"openalex":"https://openalex.org/W4241965367","doi":"https://doi.org/10.1016/j.bmcl.2004.11.072"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2004.11.072","doi":"https://doi.org/10.1016/j.bmcl.2004.11.072","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2004.11.072","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4241965367"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033757115","display_name":"Sompong Wattanasin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sompong Wattanasin","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA. sompong.wattanasin@pharma.novartis.com","Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA. sompong.wattanasin@pharma.novartis.com","institution_ids":[]},{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059330877","display_name":"Joerg A. Kallen","orcid":"https://orcid.org/0000-0002-9389-9056","observed_orcids":["https://orcid.org/0000-0002-9389-9056"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Joerg Kallen","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064493864","display_name":"Stewart Myers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stewart Myers","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102975592","display_name":"Qin Guo","orcid":"https://orcid.org/0009-0003-2943-0688","observed_orcids":["https://orcid.org/0009-0003-2943-0688"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qin Guo","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110858536","display_name":"Michael L. Sabio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Sabio","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111612336","display_name":"Claus Ehrhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Claus Ehrhardt","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111974216","display_name":"Rainer Albert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Rainer Albert","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017238214","display_name":"Ulrich Hommel","orcid":"https://orcid.org/0000-0001-6532-9155","observed_orcids":["https://orcid.org/0000-0001-6532-9155"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ulrich Hommel","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107843627","display_name":"Gisbert Weckbecker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gisbert Weckbecker","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010666641","display_name":"Karl Welzenbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Karl Welzenbach","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026397986","display_name":"Gabriele Weitz\u2010Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gabriele Weitz-Schmidt","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Basel 4002, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Basel 4002, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5033757115"],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.8334,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.89832606,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"15","issue":"4","first_page":"1217","last_page":"1220"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.39329999685287476,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.39329999685287476,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.25929999351501465,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.11569999903440475,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lfa-1","display_name":"LFA-1","score":0.8859999775886536},{"id":"https://openalex.org/keywords/integrin-inhibitors","display_name":"integrin inhibitors","score":0.8360000252723694},{"id":"https://openalex.org/keywords/1-4-diazepines","display_name":"1,4-diazepines","score":0.8080000281333923},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5709999799728394},{"id":"https://openalex.org/keywords/biological-evaluation","display_name":"biological evaluation","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9313989877700806},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4170725345611572},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.39376741647720337},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2218371331691742},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19953757524490356}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bmcl.2004.11.072","doi":"https://doi.org/10.1016/j.bmcl.2004.11.072","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2004.11.072","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W141774154","https://openalex.org/W1479880028","https://openalex.org/W1942794198","https://openalex.org/W1965695253","https://openalex.org/W1969394150","https://openalex.org/W1972871744","https://openalex.org/W1976245977","https://openalex.org/W1991606736","https://openalex.org/W1994904386","https://openalex.org/W1994956550","https://openalex.org/W1997440323","https://openalex.org/W2000824640","https://openalex.org/W2003920577","https://openalex.org/W2009345333","https://openalex.org/W2013615026","https://openalex.org/W2015313829","https://openalex.org/W2022431638","https://openalex.org/W2033522742","https://openalex.org/W2033708431","https://openalex.org/W2040072610","https://openalex.org/W2041556515","https://openalex.org/W2043739531","https://openalex.org/W2045576389","https://openalex.org/W2050681882","https://openalex.org/W2052307789","https://openalex.org/W2053029035","https://openalex.org/W2063330553","https://openalex.org/W2063559096","https://openalex.org/W2069914253","https://openalex.org/W2075732942","https://openalex.org/W2079829633","https://openalex.org/W2085855286","https://openalex.org/W2085979652","https://openalex.org/W2102324547","https://openalex.org/W2144856110","https://openalex.org/W2152976783","https://openalex.org/W2157605227","https://openalex.org/W2170877356","https://openalex.org/W2178216404","https://openalex.org/W2179076164","https://openalex.org/W2299363478","https://openalex.org/W2949097810"],"related_works":["https://openalex.org/W2950649083","https://openalex.org/W4246426061","https://openalex.org/W2912026908","https://openalex.org/W2102753419","https://openalex.org/W2286394330","https://openalex.org/W4385986366","https://openalex.org/W1999367501","https://openalex.org/W2171505728","https://openalex.org/W2328479692"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4241965367","counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-05-12T00:00:00"}
